Star Price To Sales Ratio from 2010 to 2024
| STRR Stock | USD 3.04 0.24 8.57% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 0.35726434 | Current Value 0.34 | Quarterly Volatility 2.9883789 |
Check Star Equity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Star Equity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 924.4 K or Selling General Administrative of 15.6 M, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.12 or PTB Ratio of 0.24. Star financial statements analysis is a perfect complement when working with Star Equity Valuation or Volatility modules.
Star | Price To Sales Ratio |
Latest Star Equity's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Star Equity Holdings over the last few years. Price to Sales Ratio is figured by comparing Star Equity Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Star Equity sales, a figure that is much harder to manipulate than other Star Equity Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Star Equity's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Star Equity's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.19 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Star Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 2.71 | |
| Geometric Mean | 1.32 | |
| Coefficient Of Variation | 110.35 | |
| Mean Deviation | 2.46 | |
| Median | 0.84 | |
| Standard Deviation | 2.99 | |
| Sample Variance | 8.93 | |
| Range | 8.9106 | |
| R-Value | (0.54) | |
| Mean Square Error | 6.82 | |
| R-Squared | 0.29 | |
| Significance | 0.04 | |
| Slope | (0.36) | |
| Total Sum of Squares | 125.03 |
Star Price To Sales Ratio History
About Star Equity Financial Statements
Star Equity shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Star Equity investors may analyze each financial statement separately, they are all interrelated. The changes in Star Equity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Star Equity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 0.36 | 0.34 |
Pair Trading with Star Equity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Star Equity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will appreciate offsetting losses from the drop in the long position's value.Moving together with Star Stock
| 0.62 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Star Stock
| 0.86 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.78 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.54 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.52 | PHVS | Pharvaris BV | PairCorr |
| 0.41 | ESLAW | Estrella Immunopharma | PairCorr |
The ability to find closely correlated positions to Star Equity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Star Equity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Star Equity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Star Equity Holdings to buy it.
The correlation of Star Equity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Star Equity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Star Equity Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Star Equity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Star Stock Analysis
When running Star Equity's price analysis, check to measure Star Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Equity is operating at the current time. Most of Star Equity's value examination focuses on studying past and present price action to predict the probability of Star Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Equity's price. Additionally, you may evaluate how the addition of Star Equity to your portfolios can decrease your overall portfolio volatility.